Notably, these low-Wnt or P-N organoids were derived from a variety of patients with FAP without obvious associations with APC genotype or clinical features such as proton pump inhibitor usage, gastric polyp phenotype, or intestinal polyp burden (Table 1 and Supplemental Table 1). This evidence concerns the gene FAP and intestinal polyp.